Smith, C. C., Lasater, E. A., Zhu, X., Lin, K. C., Stewart, W. K., Damon, L. E., . . . Shah, N. P. (2013). Activity of ponatinib against clinically-relevant AC220-resistant kinase domain mutants of FLT3-ITD. American Society of Hematology.

Smith, Catherine C., Elisabeth A. Lasater, Xiaotian Zhu, Kimberly C. Lin, Whitney K. Stewart, Lauren E. Damon, Sara Salerno, and Neil P. Shah. Activity of Ponatinib against Clinically-relevant AC220-resistant Kinase Domain Mutants of FLT3-ITD. American Society of Hematology, 2013.

Smith, Catherine C., et al. Activity of Ponatinib against Clinically-relevant AC220-resistant Kinase Domain Mutants of FLT3-ITD. American Society of Hematology, 2013.